Deficient Apoptotic Process in Cisplatin-Resistant L1210 Cells Cannot Account for the Cellular Response to Various Drug Treatments
- 29 May 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 234 (3) , 573-577
- https://doi.org/10.1006/bbrc.1997.6674
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Expression of bcl-xL can confer a multidrug resistance phenotypeBlood, 1995
- Cisplatin Resistance in a Murine Leukemia Cell Line Is Associated with a Defective Apoptotic ProcessExperimental Cell Research, 1995
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- DNA excision‐repair synthesis is enhanced in a murine leukemia L1210 cell line resistant to cisplatinEuropean Journal of Biochemistry, 1993
- High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis.Proceedings of the National Academy of Sciences, 1992
- Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermiaBiochemical Pharmacology, 1990
- Short-termcis-diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cellsCancer Chemotherapy and Pharmacology, 1990
- Interaction of Platinum Antitumor Compounds with DNAPublished by Springer Nature ,1990
- Overexpression of Metallothionein Confers Resistance to Anticancer DrugsScience, 1988
- Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)Biochemistry, 1988